Jiangxi Yixinda Medical Equipment Co., Ltd.

Yixinda Medical is a comprehensive technology service enterprise dedicated to promoting the development of interventional medicine industry, the popularization and application of interventional technology, and the improvement of interventional discipline capabilities. The company currently has over 230 employees, and its core team members all have years of national market management experience at listed companies. In the more than five years since its establishment, the company has established regular business cooperation with more than 150 hospitals in Jiangxi and the Guangdong-Guangxi region. Its market coverage in Jiangxi is nearly 90%, its market share is nearly 50%, and its regional win rate has exceeded 60% for four consecutive years. It has helped more than 60 clients build and rapidly develop interventional disciplines "from scratch", assisted clients in carrying out nearly 100 different types of interventional procedures at various levels including "cardiovascular, peripheral, neuro, respiratory, digestive, gynecological", accumulated support for over 25,000 surgical procedures, and achieved doubling sales performance year after year. Since its establishment, the company has always adhered to the corporate development philosophy of "staying true to our original aspiration and benefiting patients". Centering on the construction and development needs of interventional disciplines in hospitals of various levels, it has built a comprehensive "full-domain" product system and a "full-cycle" service system, providing clients with "one-stop" overall solutions for discipline construction. Technical service system: discipline framework establishment, technical talent training, expert support and mentoring, surgical application accompaniment, discipline operation management, regional resource integration, discipline brand promotion. Hardware service system: site design and construction, supporting equipment sales, consumables delivery and supply, equipment and instrument maintenance, information platform construction. Product system: General agent of Siemens angiography systems in Jiangxi, Guangxi, and Guangdong; core product general agent or first-level agency platform in Jiangxi Province for well-known domestic and international enterprises such as Boston Scientific, Johnson & Johnson, Abbott, Medtronic, MicroPort, APT, JW Medical, Pushkang, Huasheng, and Mindray. In 2022, it launched a groupization strategy, established Guangdong and Guangxi branches, entered the Guangdong-Guangxi market, and successfully achieved regional model replication. In 2023, it launched an industrialization development strategy and independently developed a global interconnected digital surgical system. In 2024, it carried out close business cooperation with the provincial medical investment state-owned enterprise platform and jointly established a medical investment discipline service company. In 2025, the Sichuan-Chongqing branch was established to incubate a western value highland.